| dc.creator |
Guney, M. |
|
| dc.creator |
Mungan, T. |
|
| dc.creator |
Karahan, N. |
|
| dc.creator |
Erdemoglu, E. |
|
| dc.date |
2008-01-01T01:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:54:56Z |
|
| dc.date.available |
2021-12-03T11:54:56Z |
|
| dc.identifier |
c61c291f-fc56-4482-ae30-db31fee04878 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/c61c291f-fc56-4482-ae30-db31fee04878/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94780 |
|
| dc.description |
Objective: To study whether endometrioid type malignant endometrial polyps (MEP) are different from endometrium cancer not associated with polyps (ECNAP) in means of immunohistochemical expressions of MMP-2. MMP-9 and COX-2. Methods: Archived tissue samples of eight MER eight ECNAP and 16 benign endometrial polyps were selected and immunohistochemically analyzed for MMP-2, MMP-9 and COX-2 expression. Results: MMP-2 and MMP-9 were overexpressed in ECNAP compared to MEP and benign endometrial polyps (p < 0.05). MMP-2 and MMP-9 expressions were not different in the malignant part of MEP, benign part of MEP and benign endometrial polyps. COX-2 expression was found to be higher in benign lesions, although this was not statistically significant. Conclusion: Similar immunohistochemical expression of MMP-2. MMP-9 and COX-2 within a polyp and with benign polyps may indicate an immunohistochemically indolent characteristic of MEP. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Immunohistochemical expression of MMP-2, MMP-9 and COX-2 in Stage IA malignant polyps of the endometrium |
|
| dc.type |
info:eu-repo/semantics/article |
|